Re:AstraZeneca may have provided incomplete efficacy data NIAID
by Neil44 on Tuesday March 23, 2021 @08:11AM
(#26554101)
The company licensing and distributing their vaccine at cost and many times cheaper than the others is getting lots of negative stories and comments in the media, who could possibly benefit from this.
[ Parent
| on HN ]
There are no comments on this comment yet.